Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors

Yasuhide Yamada, Tomohide Tamura, Noboru Yamamoto, Tatsu Shimoyama, Yutaka Ueda, Haruyasu Murakami, Hitoshi Kusaba, Yoshikazu Kamiya, Hideo Saka, Yusuke Tanigawara, J. Patrick McGovren, Yutaka Natsumeda

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences